يعرض 1 - 10 نتائج من 100 نتيجة بحث عن '"Hernandez, Maria-Clemencia"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Jones, B, Kwok C, Kung A. Effect ofradioactive iodine therapy on cytokine production in Graves'disease; transient increases IL-10 and tumor necrosis factorin interleukin-4 alpha, with longer term increases in interferon-gamma production. J Clin Endocrinol Metab 1999; 84 (11).; Weetman, Antonhy. Graves' Disease. N Engl J Med 2000; 343 (17):1236-48.; Marcocci, Bartalena L, Tanda, M L. Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study. J Clin Endocrinol Metab 2001; 86: 3562-67.; Wiersinga W, Prummel M. An evidence-based approach to the treatment of graves' ophthalmopathy . Endocrinol Metab Clin North Am 2002; 29 (2).; Bahn RS, Gorman CA. Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol Metab Clin North Am 1987; 16:391-407.; Bartalena L, Marcocci C, Bogazzi F. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989; 321: 1349-52.; Bartalena L, Marcocci C, Bogazzi F, Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998; 338: 73-8.; Bartalena L, Marcocci C, Tanda ML. Cigarette smoking and treatment outcomes in Graves' ophthalmopathy. Ann Intera Med 1998; 129: 623-35.; Wierssinga W. Preventing Graves' ophthalmopathy. N Engl J Med 1998; 338: 121-22.; Bonavolonta G, Muto P, Lombardi, Gaetano. Orbital Scintigraphy with [111 In-Diethylenetriamine Pentaacetic Acid-D-Phel ]-Octreotide Predicts the Clinical Response to Corticosteroid Therapy in Patients with Graves' Ophthalmopath. J clin Endocrinol Metab 1998; 83 (11).; Kahaly G, Rosler, H P, Pitz, S. Low- Versus High-Dose Radiotherapy for Graves' Ophthalmopathy: A Randomized, Single Blind Trial. J clin Endocrinol Metab 2003; 85 (1).; Wiersinga W, Prummel M F Pathogenesis of Graves' Ophthalmopathy-Current Understanding. J Clin Endocrinol Metab 2001; 86 (2).; Smith T, Koumas L, Gagnnon AM, Bell , A. Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophtalmopathy. J clin Endocrinol Metab 2002; 87 (1).; Bartalena L, Tana, M L, Manetti, L. Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study. J Clin Endocrinol Metab 2001; 86 (8).; Dieguez C, Pavia, C, Yturriaga, R. Tiroides. Madrid, McGraw Hila, Interamericana, 1999, p. 244.; Greenspan F, Strewler G Endocronologia Básica y Clinica. México, Manual Moderno, 1997, p 267-269.; Tallsted L, Lundell , G, Torring, O et al. Ocurrence of ophthalmopathy after treatment for Graves hiperthyroidism. N Engl J Med 1999; 326: 1733.; Wengrowicz S E. Prevención de la oftalmopatía tiroidea. Endocrinol Nut.2001; 48 (3).; Bartalena L, Marcocci, C and Pinchera A. Graves 'ophthal- mopathy: a preventable disease? Eur J Endocrinol 2002; 146:457-61.; https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/346/374Test; Núm. 2 , Año 2004 : Abril – Junio; 77; 72; 13; Revista Repertorio de Medicina y Cirugía; https://repositorio.fucsalud.edu.co/handle/001/2254Test; https://doi.org/10.31260/RepertMedCir.v13.n2.2004.346Test

  6. 6
    دورية أكاديمية

    المساهمون: F. Hoffmann-La Roche

    المصدر: Journal of Neurodevelopmental Disorders ; volume 14, issue 1 ; ISSN 1866-1947 1866-1955

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية
  10. 10
    دورية أكاديمية